AustralianSuper members are switching to rival superannuation funds faster than ever before, leaving the country’s largest retirement savings manager some $250 million worse off over the last year.

The MarketWatch News Department was not involved in the creation of this content. IRVINE, Calif., Jan. 27, 2026 /PRNewswire/ -- Conexus is excited to kick off 2026 with a thoughtful yet aggressive ...

IRVINE, Calif., Jan. 27, 2026 /PRNewswire/ -- Conexus is excited to kick off 2026 with a thoughtful yet aggressive organic growth strategy, expanding into three new markets beyond its current West ...

A large warehouse and industrial site in Solon has been sold by its Beachwood owners to a Chicago-based food distribution company. JLL Managing Director David Stecker said the site sold Dec. 16, for ...

(RTTNews) - Mutares SE & Co. KGaA (MUX.DE, MUTRF), a Germany-based holding company, on Tuesday announced it has signed an agreement to sell portfolio company Conexus S.p.A. to Advanced Technology ...

Example elevations presented to Monument City Council for Conexus Lot 2. Courtesy of the town of Monument. On Monday, the Monument Town Council unanimously approved a Final Planned Unit Development ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Meet 2025 Most Admired CEOs ...

CHESTERFIELD COUNTY, Va. (WRIC) — Conexus brings kids in Richmond-area schools more than just the gift of sight. It also brings the gift of confidence. 8News has partnered with Conexus for its annual ...

A U.S. neurotechnology startup called Paradromics is gaining momentum in the fast-growing field of brain-computer interfaces. The FDA has approved its first human trial built to test whether its fully ...

The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment. AUSTIN, Texas--(BUSINESS ...

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...